Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 2B2 (CYP2B2) is an enzyme found primarily in rat liver, belonging to the cytochrome P450 superfamily of heme-thiolate monooxygenases. It catalyzes the oxidative metabolism of a variety of endogenous and exogenous compounds, including drugs, toxins, and steroids. CYP2B2 is inducible by certain xenobiotics such as phenobarbital, a property leveraged in experimental pharmacology to study hepatic drug metabolism and enzyme regulation. Like other P450s, it functions via a complex catalytic cycle involving electron transfer and formation of a reactive iron-oxo species which oxidizes substrates. While CYP2B2 itself is not a direct target for human therapy, its homologs (such as human CYP2B6) are clinically significant due to their impact on drug metabolism, pharmacokinetics, and potential for adverse drug interactions.
Substrate oxidation via monooxygenase catalysis; Induction by xenobiotics acting as transcriptional activators
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 2B2 (CYP2B2).